Evidence map›Paper›PMID 40224273›Full record

ArticleResearch and practice in thrombosis and haemostasis2025

Sexuality and bleeding in von Willebrand disease.

Calvin B van Kwawegen, Hester Pastoor, Jeroen Eikenboom, Karin Fijnvandraat, Paula Ypma, Floor C J I Heubel-Moenen, Karin P M van Galen, Evelien P Mauser-Bunschoten, Karina Meijer, Saskia E M Schols and 7 more

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Von Willebrand disease: more than just a bleeding disorder.Research and practice in thrombosis and haemostasis · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Calvin B van KwawegenDepartment of Hematology, Erasmus Medical Center, University Medical Center, Rotterdam, the Netherlands.
Hester PastoorDivision of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Jeroen EikenboomDepartment of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Centre, Leiden, the Netherlands.
Karin FijnvandraatDepartment of Pediatric Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Paula YpmaDepartment of Hematology, Hagaziekenhuis, Den Haag, the Netherlands.
Floor C J I Heubel-MoenenDepartment of Hematology, Maastricht University Medical Center, Hemophilia Treatment Centre Nijmegen-Eindhoven-Maastricht, Maastricht, the Netherlands.
Karin P M van GalenDepartment of Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Evelien P Mauser-BunschotenDepartment of Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Karina MeijerDepartment Hematology, University Medical Center Groningen, Groningen, the Netherlands.
Saskia E M ScholsDepartment of Hematology, Radboud University Medical Center, Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Nijmegen, the Netherlands.
Marjon H CnossenDepartment of Pediatric Hematology and Oncology, Erasmus Medical Center, Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Johanna G van der BomDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Joke de MerisNetherlands Hemophilia Society, Nijkerk, the Netherlands.
Ferdows AtiqDepartment of Hematology, Erasmus Medical Center, University Medical Center, Rotterdam, the Netherlands.
Marieke J H A KruipDepartment of Hematology, Erasmus Medical Center, University Medical Center, Rotterdam, the Netherlands.
Frank W G LeebeekDepartment of Hematology, Erasmus Medical Center, University Medical Center, Rotterdam, the Netherlands.
WiN Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sexuality is a fundamental aspect of quality of life, often impacted by chronic or inherited diseases like von Willebrand disease (VWD), an inherited bleeding disorder characterized by mucosal bleeding, including heavy menstrual bleeding (HMB). To date, no studies have investigated the impact of VWD on sexuality. Objectives: This study aimed to identify sexual restrictions and symptoms in VWD patients, differentiating between men and women and between premenopausal and nonmenstruating women. Methods: We performed a nationwide, multicenter, prospective cohort study, the Willebrand in the Netherlands-Prospective study, including adult VWD patients (>18 years) who completed questionnaires on sexuality and health-related quality of life (SF-36). Additional data were collected via blood tests and a self-reported bleeding assessment tool (International Society on Thrombosis and Haemostasis Bleeding Assessment Tool). Results: We included 549 VWD patients with a median age of 51 years (IQR, 37-66 years), of whom the majority were women ( Conclusion: Women with VWD experience more sexual restrictions than men and report more postcoital bleeding than the general population. Premenopausal women are particularly affected, mostly due to HMB. This highlights the need for health care providers to address sexual health during consultations and treat HMB to improve overall care for VWD patients.

Indexed as

hemorrhagemenorrhagiaquality of lifesexualityvon Willebrand disease

Identifiers

PMID40224273
PMCPMC11992386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.